Curative Biotechnology, Inc. yalengeza lero kuti kampaniyo yapita patsogolo mu kafukufuku wake wa Toxicology wa Good Laboratory Practice (GLP).
Kafukufuku wapano adapangidwa kuti aziyesa kulekerera, ma pharmacokinetics ndi kawopsedwe kalikonse kamene kamakhala m'deralo kapena kachitidwe ka metformin kamene kamayendetsedwa ndi kuperekedwa kwapamaso. Phunziroli lidzawunikanso kufalikira kwa minofu ya m'maso.
Kafukufuku wa toxicology wa Good Laboratory Practice (GLP) ndiwofunikira pakulemba kwa FDA Investigational New Drug (IND).
Kulekerera kwa maso kumaphatikizanso kuwunika kwa dosing, kuwunika kwachipatala kawiri tsiku lililonse (kuwunika kwa machitidwe/zizindikiro zachipatala ndikuyang'anitsitsa maso), kuyezetsa maso ndi dokotala wamaso wovomerezeka ndi Board-certified Veterinary ophthalmologist malinga ndi sikelo yosinthidwa ya Hackett-McDonald, ndi ocular histopathology. .
Pansi pa mgwirizano wa Cooperative Research and Development Agreement (CRADA), National Eye Institute (NEI) ndi Curative Biotechnology, Inc. adzagwirizana kuti awunike mawonekedwe a Curative ocular metformin m'maphunziro azachipatala pochiza matenda apakati komanso ochedwa Age-Related Macular Degeneration. (AMD) matenda.
ZOMWE MUNGACHITE PA NKHANIYI:
- Kulekerera kwa maso kumaphatikizanso kuwunika kwa dosing, kuwunika kwachipatala kawiri tsiku lililonse (kuwunika kwa machitidwe/zizindikiro zachipatala ndikuyang'anitsitsa maso), kuyezetsa maso ndi dokotala wamaso wovomerezeka ndi Board-certified Veterinary ophthalmologist malinga ndi sikelo yosinthidwa ya Hackett-McDonald, ndi ocular histopathology. .
- The current study is designed to gauge tolerability, pharmacokinetics and any local or systemic toxicity of reformulated metformin when administered by topical ocular delivery.
- Kafukufuku wa toxicology wa Good Laboratory Practice (GLP) ndiwofunikira pakulemba kwa FDA Investigational New Drug (IND).
